European Journal of Gastroenterology & Hepatology

Papers
(The H4-Index of European Journal of Gastroenterology & Hepatology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Paper Alert36
Paper alert34
Effectiveness and safety of newly introduced endoscopic submucosal dissection in a Western center: a real-life study31
String used for oesophageal capsule endoscopy: help or hindrance?31
Quality of care in inflammatory bowel disease from patient’s perspective using QUOTE-IBD: a Greek multicenter prospective study27
Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome24
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation24
Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection23
Correlating endoscopic findings with pathology to optimize biopsy strategies in gastritis: insights from a large cohort study21
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites19
Comment on ‘Home-based transcutaneous electrical acupuncture-point stimulation for depressive symptoms in inflammatory bowel disease: a randomized feasibility study’19
Prevalence, risk factors, and clinical outcomes of extraintestinal manifestations in inflammatory bowel disease: a population-based study in china18
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease17
Cardiac involvement in Wilson’s disease: a retrospective cohort study16
Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study16
Stereotactic body radiotherapy versus radiofrequency ablation as initial treatment of small hepatocellular carcinoma15
High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus15
0.93543291091919